We identified impaired osteoblast differentiation and function as the primary driver of osteopenia, as their dysfunction not only reduced bone formation but also significantly lowered Opg expression, likely contributing to increased osteoclast activation (Fig. 6n) as confirmed by co-culture experiments (Fig. 2). The gene discussed is TNFRSF11B; the disease is Osteopenia.